Definitive Healthcare stock surges 13% on Advent buyout offer
Definitive Healthcare (NASDAQ:DH) shares rose 13% after Advent International offered to buy the company for $1.02 per share, a 36% premium over its 60-day average. The deal requires approval from a special committee and Jason Krantz's stock rollover. Definitive Healthcare also appointed Clay Ritchey as CEO, replacing Kevin Coop.
How this was made
The 30-second read
Why it matters
The non‑binding offer introduces a clear catalyst for DH's share price, with a sizable premium that may attract other suitors or trigger a bidding war.
Market read
First‑report M&A news for DH, prompting a 13% price jump and creating short‑term trading opportunities.
What to watch
Potential financing contingencies, regulatory review, and integration risks for Advent International.
Background
Definitive Healthcare (DH) provides data and analytics to the healthcare industry; Advent International is a private‑equity firm with prior investments in health‑tech.
Ticker impact
Advent International submitted a non-binding cash offer of $1.02 per share for Definitive Healthcare, driving the stock up 13% on the announcement.
Expect further upside toward the $1.02 offer price, with potential volatility pending special committee approval.
First disclosure of a material M&A proposal for a listed micro‑cap; the premium and immediate share rally indicate strong market reaction.
Market effects
Healthcare data and analytics sector may see consolidation pressure as private equity shows interest.
U.S. small‑cap market could experience a brief lift from the deal news.
Limited to investors tracking M&A activity in the health‑tech space.
Counterpoint
If the special committee deems the offer insufficient or seeks higher bids, the stock could retreat sharply.
Key entities
- CompanyDefinitive Healthcare Corp.
NASDAQ‑listed provider of healthcare data and analytics.
- Private‑Equity FirmAdvent International
Potential acquirer offering $1.02 per share cash.
